Leaflet VIRACEPT 625mg film-coated tablets

Product code:
W41752001
Quantity:
120
Indicated for:
HIV-1 infection
Route of administration:
oral
Substance:
nelfinavir (antiretroviral)
ATC
J05AE04 — Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors

Precautions:

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Nelfinavir is an antiretroviral medication used for the treatment of HIV-1 infection. It belongs to the class of protease inhibitors and works by blocking the HIV protease enzyme, preventing viral replication.

The medication is taken orally, as directed by a doctor, usually two or three times daily with food. It is important for patients to follow the treatment regimen to prevent the development of viral resistance.

Patients should be aware of potential side effects, such as diarrhea, nausea, or abdominal pain. It is important to inform the doctor of any unusual symptoms.

Common side effects include diarrhea, nausea, and abdominal pain. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about VIRACEPT 625mg

Substance:
nelfinavir
Date of latest medicines list:
01-07-2013
Product code:
W41752001
Concentration:
625mg
Pharmaceutical form:
film-coated tablets
Quantity:
120
Product type:
Original
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Pharmaceutical forms available for nelfinavir

Concentrations available for nelfinavir

  • 250mg
  • 50mg/g
  • 625mg